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ABSTRACT
Objective: The study’s purpose has been to evaluate the association of socio-demographic and clinical variables 
with the general and specific mortality from prostate cancer. Methods: This is a retrospective study that was 
carried out through the analyses of medical records from 1,290 men diagnosed with prostate cancer over the 
period from 2000 to 2006. Results: Considering the 1,290 men, 758 were alive, 308 had died from prostate 
cancer, and 224 had died from other causes. Those that were associated with death from prostate cancer include: 
Gleason score > 9, Prostate Specific Antigen (PSA) > 20 and the presence of metastasis. Furthermore, there 
were those associated with death due to other causes, as follows: widowers, admission to the hospital without 
diagnosis and without treatment, and also PSA > 50. Conclusion: Clinical variables predominated with regards 
to prostate cancer-specific mortality. On the other hand, socio-demographic variables prevailed towards deaths 
originated from other causes.
Descriptors: Prostate Neoplasms, Mortality, Men’s Health, Public Policies. 
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RESUMO
Objetivo: Avaliar a associação de variáveis sociodemográficas e clínicas com 
a mortalidade geral e específica por câncer de próstata. Método: Estudo 
retrospectivo de 1290 homens diagnosticados com câncer de próstata entre 
2000 e 2006. Consultou-se prontuários, Sistema de Registro Hospitalar e 
Sistema de Informações sobre Mortalidade. Resultados: Dos 1290 homens, 
758 estavam vivos, 308 morreram por câncer de próstata e 224 por outras 
causas. Associaram-se ao óbito por câncer de próstata: escore de Gleason > 
9, PSA > 20 (entre 2,82 e 5,55 vezes) e presença de metástase. Associaram-
se ao óbito por outras causas: estado civil viúvo, ingresso no hospital sem 
diagnóstico e sem tratamento e PSA > 50. Conclusão: Variáveis clínicas 
predominaram sobre a mortalidade específica por câncer de próstata, já 
variáveis sociodemográficas em óbitos por outras causas.    
Descritores: Neoplasias da Próstata, Mortalidade, Saúde do Homem, 
Políticas Públicas.
RESUMEN
Objetivo: Evaluar la asociación de las variables sociodemográficas y 
clínicas con la mortalidad general y específica por cáncer de próstata. 
Métodos:Estudio retrospectivo de 1.290 hombres con cáncer de próstata en 
el período del 1 de enero de 2000 al 31 de diciembre de 2006. Resultados: De 
los 1.290 hombres, 758 estaban vivos, 308 murieron por cáncer de próstata 
y 224 por otras causas. Se asociaron con la muerte por cáncer de próstata: 
Gleason puntuación >9, PSA>20 (entre 2,82 y 5,55 veces) y metástasis. Ellos 
se asociaron con muerte por otras causas: el estado civil viuda, la admisión 
al hospital diagnosticar y sin tratar y el PSA>50. Conclusión: Las variables 
clínicas predominaron sobre la mortalidad específica por cáncer de próstata, 
ya variables sociodemográficas en muertes por otras causas.. 
Descriptores: Neoplasias de la Próstata, Mortalidade, Salud del Hombre, 
Políticas Públicas.
INTRODUCTION
Prostate cancer (PC) is the second most malignant 
tumor in men and the sixth leading cause of death in men 
worldwide.1 In Brazil, except for non-melanoma skin cancer, 
it represents the most prevalent malignant tumor in men, for 
28.6% of the cases of male cancers predicted for 2016/2017.2 
being the second cause of cancer mortality by gender.3 The 
estimated incidence for 2016 was 61,200, with an estimated 
risk of 61.82 new cases every 100,000 men.2
Its risk factors are age, black race, and family history.2,4,5 
Seventy-two percent of cases occur in developed countries 
and account for 56% of worldwide mortality.4 In Brazil, 
there is a trend towards increased incidence and mortality,6 
between 1980 and 2006 the increase in mortality from 
PC corresponded to 100% in cases from cities in the 
interior of the country, contrasting with an increase of 
40.8% in those living in the capitals.7 North America and 
Oceania tend to show a stabilization in the incidence of 
this neoplasm, and show a reduction in mortality, a result 
of the detection of the disease in the early stages since the 
1990s with the introduction of Prostate Specific Antigen 
(PSA); of performing radical prostatectomy as a surgical 
treatment; the evolution of radiotherapy and hormone 
therapy,5,8 reaching a 39% reduction in mortality between 
1991 and 2007, when the mortality rate was equal to that 
of 1975, a time prior to the clinical use of PSA as tumor 
marker for PC.5
One of its characteristics is to present in an insidious way 
and to undertake, in the majority, men over 65 years old, 
2 with other causes of death concurring for the outcome, 
being the main ones cardiovascular, respiratory and other 
primary neoplasias.9-11
The Espírito Santo is a State from the Southeastern 
Region with a population of 3,514,952 inhabitants, 12 
with gross rates of mortality of PC that rose from 1.96 
cases/100,000 inhabitants in 1980, when it ranked 16th in 
the mortality ranking for this disease, to 13.93 cases/100,000 
inhabitants in 2014.13
Given the aforementioned, this study aims to assess the 
relationship of socio-demographic and clinical variables 
with both general and specific PC mortality in men bearing 
this disease, which were treated at a referral hospital in 
oncology. 
METHODS
It is a retrospective cohort study of secondary data on 
PC mortality was collected, with data from men diagnosed 
with neoplasm between January 1st, 2000 and December 
31st, 2006, using the Hospital Registry of Cancer from 
the Hospital Santa Rita de Cássia/Associação Feminina de 
Educação e Combate ao Câncer (HSRC/Afecc).
The HSRC/Afecc is a general and philanthropic hospital 
for oncology care. It consists of two Centers of Attention 
of High Complexity in Oncology, as established by the 
Ordinance No. 741, of December 19th, 2005.14
Included in the study were men with pathology-proven 
PC, who had received care in the hospital and were enrol-
led in the Health Information System from the Hospital 
Registry of Cancer during the aforesaid period.
In the composition of the sample, the exclusion criteria 
were the impossibility of determining the initial clinical 
staging, the registration of only one consultation in the 
hospital, the cases of residents in other states and the 
absence of information about the municipality of residence.
The initial sample consisted of 1,500 men; nevertheless, 
174 (11.6%) were excluded from the study because they did 
not present enough information to determine the initial 
staging; six (0.4%), because they had only one consulta-
tion at HSRC/Afecc; 25 (1.6%), because they came from 
other states, and five (0.3%), due to the lack of information 
about the municipality of origin, thus remaining for the 
analysis 1,290 men.
For the information collection, the Tumor Registry 
Form and the medical records of the men served with a 
diagnosis of the neoplasm were used, as well as the Health 
Information System-Hospital Registry of Cancer records 
from the HSRC/Afecc. Data on mortality and its underlying 
cause were obtained by consulting the Mortality Informa-
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tion System in the Espírito Santo State. The collection of 
these data occurred over the period from October 2011 
to March 2012.
The purpose of the medical records was to collect data 
that had not been included in the Tumor Registry Record 
or that had been recorded after the case was registered 
in the hospital system, a situation that occurs throughout 
the tumor’s birthday. For this purpose, a data collection 
form was used.
In order to identify the cases with an outcome (death) 
occurred between 2000 and 2011, we used the Mortality 
Information System from the Espírito Santo State. This 
database is made up of death certificates collected by the 
State Health Office and has the objective of providing 
health managers, researchers and society entities with the 
most relevant information for the definition of priorities 
in programs of prevention and control of diseases.15
The PC was assigned the situations in which C61 was 
specified as the basic cause of death, according to the 
10th edition of the International Classification of Disea-
ses, approved in 1989, the last update in which the ICD 
C61 corresponding to PC was maintained,16 occurred in 
the year 2008.
Herein, the following eleven variables were analyzed: 
age at diagnosis, race/skin color, education level, marital 
status, origin and diagnosis and previous treatments (socio-
demographic variables); staging, PSA value, histological 
Gleason score and presence of metastases and treatments 
and associations of modalities (clinical variables).
Data were organized in the Microsoft Office Excell 2007 
for Windows program and analyzed using the Statistical 
Package for Social Sciences (SPSS), version 18.0. To evaluate 
the mortality, the patients were stratified into death and not 
death. The death was divided into PC death and death from 
other causes. The percentages of the qualitative variables 
were calculated in the groups considered. The chi-square 
test was used to measure the association between the qua-
litative variables and the groups considered. The averages, 
the medians, and the standard deviations were computed. 
For variables that presented statistical significance of 10% 
in the chi-square test, the raw odds ratio was calculated 
and adjusted by the multivariate logistic regression model. 
Logistic regression considered the non-death category as 
the standard, and the adjusted odds ratio was estimated 
for the death categories by PC and death for other causes. 
The final significance level considered was 5%.
This research is in accordance with the ethical determi-
nations established in the Resolution No. 466 of Decem-
ber 12th, 2012, of the National Commission of Ethics in 
Research and was approved by the Research Ethics Com-
mittee from the Universidade Federal do Espírito Santo 
(UFES) under the No. 253/11, on October 26th, 2011.  
RESULTS AND DISCUSSION
Regarding the 1,290 men treated with PC, 758 (58.8%) 
were alive at the end of the observation period; 308 (23.9%) 
had as their outcome the death from PC and 224 (17.4%), 
the death from other causes not related to this neoplasm.
The illiterates accounted for 16.22% of the sample; 48.58% 
had not completed primary school and approximately 4% had 
completed higher education. Considering the deaths from 
cancer studied, 51% were incomplete first-degree patients, 
63% non-whites, 69% from the metropolitan region and 60% 
referred by the Sistema Único de Saúde (SUS) [Unified Health 
System]. None of the above socio-demographic variables 
presented statistical significance with the outcomes of deaths 
due to PC or other causes. The prevalence of death in both 
PC and other causes was 70 years old and older, with 60% 
and 68% of cases, respectively (p=0.001); (76%), followed by 
single (8%) and lastly, divorced was responsible for 4% of the 
deaths. Widows presented a higher prevalence of death due 
to other causes (p=0.001). Cases with diagnosis and without 
previous treatment led to specific cause deaths, with 65% 
of cases, but were even higher in deaths from other causes, 
totaling 73% (p=0.001).
Associating the clinical variables with the outcome, it 
was observed that the initial clinical staging (p=0.001) and 
the Gleason score (p=0.001), the PSA value (p=0.001) and 
the presence of metastases (p=0.001) presented statistical 
significance (Table 1). 
Table 1 - Absolute and relative frequencies of  clinical variables according 
to the outcome in men assisted by the Hospital Santa Rita de Cássia, Vitória 
city, Espírito Santo State, from January 1st, 2000 to December 31st, 2006.
Table 2 (socio-demographic variables) and Table 3 (cli-
nical variables) were the multivariate analysis, considering 
the two outcomes, PC death and death from other causes, 
in relation to non-death, for factors that presented statis-
tical significance individually (calculation of gross odds 
ratio), first for socio-demographic variables, later for clinical 
variables. The results indicate that the age variable was no 
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longer associated with mortality in these patients, while the 
widowed civil status was associated with a 2.62-fold increase 
in the probability of death from other causes (p < 0.001, CI: 
1.66-4.12); to enter the HSRC/Afecc without diagnosis and 
without treatment increased by 1.67 times the chance of death 
by PC (p=0.034; CI: 1.04-2.7) and by 3.45 times death due 
to other causes (p=0.001, IC: 1.83-6.48), and to enter with 
diagnosis and without treatment increased by 1.84 times the 
chance of death due to other causes (p=0.027, CI 1.07-3.15) . 
The Gleason score> 6 increased from 2.21 to 9.97 times the 
probability of death by PC (p=0.001; CI: 3.38-29.28).  
Table 2 - Results of  the multivariate logistic regression analysis for the 
statistically significant socio-demographic variables by individual (raw odds 
ratio), Vitória city, Espírito Santo State, 2006.
The PSA value > 20 ng/dL increased between 4.20 and 
18.10 times the chance of death by PC (p= 0.001, CI: 2.60-
6.79 and 11.02-29.73), and > 50 ng/dL, between 2.59 and 
2.82 times that of death due to other causes (p=0.001; CI: 
1.67-4.77). The initial clinical stage 4 increased by 21.48 times 
the probability of death by PC (p=0.004; CI: 2.66-173.20), 
while the presence of metastasis increased by 18.38 times the 
death rate (p=0.001, CI: 13.06-25.86), and 1.96 times that of 
death due to other causes (p=0.002; CI: 1.27-3.03).  
Table 3 - Results of  the multivariate logistic regression analysis for the 
statistically significant clinical variables by individual (raw odds ratio), Vitória 
city, Espírito Santo State, 2006.
Table 4 (socio-demographic variables) and Table 5 (cli-
nical variables) present a multivariate analysis model, con-
sidering all variables at the same time (adjusted odds ratio). 
The Gleason score 9 (OR: 2.98, p=0.001) and 10 (OR: 9.55, 
p=0.013), PSA value > 20 (between 2.82 and 2.82) were sta-
tistically significant for PC death, and 5.55 times, p=0.001) 
and presence of metastasis (OR: 12.18; p < 0.001). Marital 
status (OR: 1.96, p=0.01), admission to HSRC/Afecc without 
diagnosis and without previous treatment (OR: 2.60, p=0.007) 
were associated with death due to other causes. PSA value 
between 50 and 100 ng/dL (OR: 2.41, p = 0.005) and> 100 
ng/dL (OR: 1.92; p=0.041).   
Table 4 - Results of  the multivariate logistic regression analysis for the 
statistically significant socio-demographic variables (adjusted odds ratio), 
Vitória city, Espírito Santo State, 2006.
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Table 5 - Results of  the multivariate logistic regression analysis for the 
statistically significant clinical variables (adjusted odds ratio), Vitória city, 
Espírito Santo State, 2006.
The greater the Gleason score and the presence of metas-
tasis, the larger the risk of death due to specific cause; PSA 
greater than 20 increased the probability of death by PC, 
however when over 50 was associated with death from other 
causes, as well as being widowed and admitted to the hospital 
without diagnosis or treatment. Clinical variables predomi-
nated on prostate cancer-specific mortality and sociodemo-
graphic variables on deaths from other causes.
Age is a well-established risk factor in the natural history 
of the disease, less than 1% of the diagnoses occur before 
the age of 50,2 which is not true when the age is above 65 
years old.2,17,18 Considered a cancer of the elderly, it has slow 
progression, about 15 years for the growth of 1 cm to the 
cube, it is possible that the increase in its incidence is due in 
part to the increase in life expectancy and the evolution of 
diagnostic methods and health information systems.19 In this 
study, more than half of all cases were 70 years old or older.
Ethnicity/skin color is a potential risk factor.20 PC is 1.6 
times more common in black men, it is possible that this 
difference is due to lifestyle and factors associated with the 
detection of the disease.2 There is no reason in order to see 
this variable with a purely biological view, it is a social varia-
ble, with marks of inequity in health,21 and influences other 
variables, such as schooling,22 and even mortality.23
Low level of education in patients with PC is a common 
finding in profile studies,17,18 when inferior to full secondary 
education and associated with intermediate risk tumors24 
are factors that increase the chance of mortality, including 
other causes. The higher level of schooling favors the PSA 
test,25 which may aid in early detection and follow-up. In the 
present study, of the patients who died of PC, more than half 
had not completed the first degree.
Prevalence of patients with married or cohabiting PC 
was characteristic of other studies.17,18 More than half of the 
men affirm that the family contributes positively to their 
health habits, helping in times of aggravation and clinical 
stability.26 The state a widowed civilian patient presented as 
a variable associated with mortality from other causes and 
may be related to the absence of the figure of a caregiver for 
this man, a fact that may make it impossible to attend the 
health unit regularly to care for chronic diseases.
The primacy of the region of metropolitan origin, in all 
categories (67.8%), is possibly related to greater access and 
accessibility to diagnosis, when compared to other regions. A 
study of mortality trends in the capitals and in the interior of 
Brazil diverges from the above when it finds, in all Brazilian 
regions, much worse mortality rates among men from the 
interior region.7
Patients from the SUS did not show statistical significance 
regarding mortality from either PC or other causes, but their 
characteristics differ from those of patients admitted by 
the private system or by agreement. Usually, these patients 
receive the diagnosis at the home service and initiate some 
treatment modality, aiming to administer a complement of 
their treatment in the hospital.
When access is assessed, those who arrive at the hospital 
without diagnosis and without treatment present a greater 
chance of mortality from other causes, which may show a 
fragility of the health system as a whole, since the man who 
has difficulty in early diagnosis and treatment opportunity 
for the PC possibly also have the other diseases.
The same interpretation can be made when assessing the 
association of the PSA value with mortality. The increase 
in this value is associated with an increase in mortality due 
to neoplasm, as can be expected, since it is a disease with 
a higher risk of progression,24 although it is also associated 
with an increased risk of mortality from causes other than 
the PC, lack of access to routine consultations for screening 
for age-related diseases in the primary health care network. 
Another possibility is that patients who presented high PSA 
(above 50 ng/dL) and died due to other causes have omitted 
their true cause, due to misconception on the death certifi-
cate, lack of hospital follow-up, lack of family knowledge or 
by occurrence of death in other locations, without access to 
the patient’s medical records, where direct complications of 
the underlying disease may have been confounding factors. 
The early diagnosis of PC allows the implementation 
of a timely and radical treatment, which often contributes 
to the complete recovery of patients.27 In the present study, 
men with initial staging (I and II) died more from other 
causes, and those with late staging III and IV) died of PC. 
The variable metastasis presented similar behavior; men with 
metastasis died more per PC, and those without metastasis, 
for other causes.
The Gleason Score is a graduation referring to the PC 
architecture standard, in which 1 would be the best-diffe-
rentiated degree. Scores from 8 to 10 have a greater chance 
of recurrence and greater lethality compared to scores 2 to 
6.28 Their scores were directly related to the probability of 
the individual dying as a result of the neoplasm, and not 
due to other causes.
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In 2008, the Health Ministry proposed the Política Nacio-
nal de Atenção Integral à Saúde do Homem (PNAISH) [Natio-
nal Policy for Integral Attention to Man’s Health], reflecting 
a yearning for society to recognize that health problems are 
a public health problem, and increase the life expectancy of 
men by reducing morbidity and mortality from preventable 
and preventable causes.29 Noting the vulnerability of the indi-
vidual, PNAISH also provides comprehensive care for each 
stage of life, with primary prevention campaigns in youth and 
adult life and the screening of common problems in old age.
This policy reflects the needs of the man with PC in Espí-
rito Santo State, a situation that probably reflects a national 
need. Variables associated with PC that result in increased 
mortality from this disease also reflect a general mortality, 
probably due to the lack of access to adequate resources or 
public policies focused on primary care and campaigns for 
the early diagnosis of chronic noncommunicable diseases, 
such as cardiovascular diseases, diabetes, and oncology. It 
is expected that further studies, after the implementation 
of the PNAISH, will reflect an improvement in the health 
conditions of this population group, showing a reduction in 
mortality parameters and a higher life expectancy for men.
Further information is required from the target population 
on the tests and methods used in the early detection of pros-
tate cancer. The education in the health of the man must begin 
from the primary formation, contributing to generations more 
attentive to the health and without misconceptions about 
the accomplishment of the exams. Educating in health and 
promoting greater accessibility are undoubtedly fundamental 
points for the success of any public policy.
The fulfillment and valorization of public health poli-
cies for men, where there is an increase and a more flexible 
schedule in the service with free demand, can be a more 
effective gateway in health care, without interfering in the 
daily work of this population. It is also suggested an active 
search through family health teams with the encouragement 
and empowerment of men towards their health, followed by 
itinerant outpatient clinics with trained health personnel to 
carry out the PC monitoring efforts.
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